BROWSE·page 57 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

Date of this Note: ____________, 2026 Original Principal Amount: $ __________
Maturity Date: December 31**, 2026**

…

EX-10.5·10-Q·CIK 1970743·ACC 0001213900-26-088751·Filed Aug 13, 2026, 09:01 ET

SUBSCRIPTION AGREEMENT

** **

THE SECURITIES ARE BEING OFFERED PURSUANT TO SECTION 4(A)(2) OF THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”) AND RULE 506(b) PROMULGATED THEREUNDER AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

Board of Directors of

RMX Industries, Inc. .

4514 Cole Avenue Suite 600,

Dallas, TX 75205

…

EX-10.4·10-Q·CIK 1970743·ACC 0001213900-26-088751·Filed Aug 13, 2026, 09:01 ET

EX-10.1

EquipmentShare.com Inc

EQUIPMENTSHARE.COM INC
2025 OMNIBUS INCENTIVE PLAN

EXECUTIVE OFFICER RESTRICTED STOCK UNIT AGREEMENT

Unless otherwise defined herein, the terms defined in the EquipmentShare.com Inc 2025 Omnibus Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Agreement, which includes the Notice of Restricted Stock Unit Grant (the “Notice of Grant”), the Terms and Conditions of Restricted Stock Unit Grant, attached hereto as Exhibit A, and all other exhibits and appendices hereto (all together, the “Award Agreement”).

NOTICE OF RESTRICTED STOCK UNIT GRANT

Participant: [] (“Participant”)

EquipmentShare.com Inc (the “Company”) has granted Participant the right to receive an Award of Restricted Stock Units (“RSUs”), subject to the terms and conditions of the Plan and this Award Agreement, as follows:

…

EX-10.1·10-Q·CIK 1693736·ACC 0001693736-26-000020·Filed Aug 13, 2026, 08:44 ET

EX-10.1

Ovid Therapeutics Inc.

337326095 v2 1. CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is made by and between Ovid Therapeutics Inc. (the “Company”) and Karen Bernstein (“Consultant”) (each, a “Party”), effective as of June 10, 2026 (the “Effective Date”). 1. ENGAGEMENT OF SERVICES. Subject to the terms of this Agreement, Consultant agrees to provide consulting services to the Company as described in Exhibit A hereto (the “Services”). Consultant shall perform all Services in compliance with all applicable laws. 2. COMPENSATION. As sole compensation for the performance of the Services, the Company will pay to Consultant the amounts on the schedule specified in Exhibit A. 3. TERM AND TERMINATION. The term of this Agreement shall begin on the Effective Date and will automatically terminate on the first anniversary of the Effective Date (the “Term”); provided, however, that the Term of this Agreement may be renewed by the Company in its sole discretion. Either Party may terminate this Agreement earlier upon written notice if the other Party materially breaches this Agreement and, if such brea

…

EX-10.1·10-Q·CIK 1636651·ACC 0001628280-26-056498·Filed Aug 13, 2026, 08:33 ET

SECOND AMENDMENT TO SERVICES AGREEMENT

This second amendment to Services Agreement dated August 12, 2026 (the “Second Amendment”)by and between Duke Robotics Corp. (NV registered company) of 10 HaRimon Street, Mevo Carmel Science and Industrial Park, Israel (the “Company”) and Mr. Yossef Balucka of Ha’Sadot Road, Talmei Elazar, Israel (the “Consultant”).

R E C I T A L S:


WHEREAS the Company and the Consultant have entered into a consulting agreement dated March 25, 2021, for the rendering of CEO consulting services by the Consultant to the Company (the “Agreement”); and

** **

…

EX-10.2·10-Q·CIK 1638911·ACC 0001213900-26-088727·Filed Aug 13, 2026, 08:30 ET

** **

AMENDEMENT

** **

Made and Signed on August 02, 2026

** **

TO CONSULTING AGREEMENT Dated March 18, 2025

** **

By and Between

** **

Duke Robotics Corp.

10 Ha’rimon St. Move Carmel Industrial and Science Park, 2069203

(Hereinafter “Company” or “Duke”)

And

Mr. Vadim Maor, ID No. 016959249

Maale Avshalom St 48, Kiryat Tiveon, Israel

(Hereinafter “Consultant”)

WHEREAS, The Company and the Consultant entered into a Consulting Agreement dated March 18, 2025 (hereinafter referred to as the “Agreement”);and

** **

WHEREAS, according to the Agreement the Company engages the Consultant as an independent consultant and the Consultant agreed to serve as a consultant to the Company and provide the Company consulting services as CTO; and

** **

WHEREAS, the Company and the Consultant desire to amend the Agreement as set forth in this Amendment;

NOW, THEREFORE, the Parties hereby agree as follows:

…

EX-10.3·10-Q·CIK 1638911·ACC 0001213900-26-088727·Filed Aug 13, 2026, 08:30 ET

EX-10.2

Candel Therapeutics, Inc.

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is made between Candel Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark Sims (the “Executive”) and is made effective as of July 6, 2026 (the “Effective Date”).

WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company on the terms and conditions contained herein; and

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.

Employment.

(a)

…

EX-10.2·10-Q·CIK 1841387·ACC 0001193125-26-347980·Filed Aug 13, 2026, 08:30 ET

EX-10.4

Candel Therapeutics, Inc.

CANDEL Therapeutics, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of Candel Therapeutics, Inc. (the “Company”) is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high-caliber directors who are not employees or officers of the Company or its subsidiaries (“Outside Directors”). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

Cash Retainers

Annual Retainer for Board Membership: $40,000 for general availability and participation in meetings and conference calls of our Board of Directors, to be paid quarterly in arrears, pro-rated based on the number of actual days served by the director during such calendar quarter. No additional compensation will be paid for attending individual meetings of the Board of Directors.

…

EX-10.4·10-Q·CIK 1841387·ACC 0001193125-26-347980·Filed Aug 13, 2026, 08:30 ET

EX-10.13

MeiraGTx Holdings plc

MEIRAGTX HOLDINGS PLC

2026 EMPLOYMENT INDUCEMENT AWARD PLAN

ARTICLE I.

** Purpose**

The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company by providing these individuals with equity ownership opportunities. Capitalized terms used in the Plan are defined in Article XI.

ARTICLE II.

** Eligibility**

Eligible Individuals are eligible to be granted Awards under the Plan, subject to the limitations described herein.

ARTICLE III.

** Administration and Delegation**

…

EX-10.13·10-Q·CIK 1735438·ACC 0001104659-26-095504·Filed Aug 13, 2026, 08:23 ET

EX-10.5

MeiraGTx Holdings plc

Certain information marked as [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential.

​

REOGEN LIMITED (formerly known as Hologen Neuro AI Limited)

DEED OF AMENDMENT TO FRAMEWORK AGREEMENT

Dated as of June 22, 2026

​

This DEED is dated June 22, 2026 and is made by and among:

PARTIES

…

EX-10.5·10-Q·CIK 1735438·ACC 0001104659-26-095504·Filed Aug 13, 2026, 08:23 ET

EX-10.12

MeiraGTx Holdings plc

MeiraGTx Holdings plc

Non-Employee Director Compensation Program

(effective as of June 10, 2026)

Non-employee members of the board of directors (the “Board”) of MeiraGTx Holdings plc (the “Company”) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. As of its effectiveness, the terms and conditions of this Program shall sup

…

EX-10.12·10-Q·CIK 1735438·ACC 0001104659-26-095504·Filed Aug 13, 2026, 08:23 ET

EX-10.14

MeiraGTx Holdings plc

MEIRAGTX HOLDINGS PLC****2026 EMPLOYMENT INDUCEMENT AWARD PLAN

​

OPTION GRANT NOTICE

Capitalized terms not specifically defined in this Option Grant Notice (the “Grant Notice”) have the meanings given to them in the 2026 Employment Inducement Award Plan (as amended from time to time, the “Plan”) of MeiraGTx Holdings plc (the “Company”).

The Company has granted to the participant listed below (“Participant”) the option described in this Grant Notice (the “Option”), subject to the terms and conditions of the Plan and the Option Agreement attached as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference.

…

EX-10.14·10-Q·CIK 1735438·ACC 0001104659-26-095504·Filed Aug 13, 2026, 08:23 ET